Howard Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$423K Sell
4,961
-54
-1% -$4.89K 0.01% 307
2026
Q2
$460K Buy
5,015
+2,046
+69% +$179K 0.01% 327
2026
Q1
$253K Sell
2,969
-2,919
-50% -$260K ﹤0.01% 296
2025
Q4
$465K Buy
5,888
+31
+0.5% +$2.43K 0.01% 320
2025
Q3
$468K Buy
5,857
+150
+3% +$12.8K 0.01% 309
2025
Q2
$519K Buy
5,707
+881
+18% +$80.4K 0.01% 285
2025
Q1
$452K Sell
4,826
-743
-13% -$66.5K 0.01% 270
2024
Q4
$506K Buy
5,569
+250
+5% +$23.9K 0.01% 287
2024
Q3
$552K Buy
+5,319
New +$542K 0.01% 265

Other funds holding CL

Howard Capital Management's CL Position: Q3 2026 in Review

Howard Capital Management reduced its Colgate-Palmolive (CL) stake by 1.1% in Q3 2026, selling an estimated $4.89K and leaving 4,961 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #307.

Howard Capital Management first reported a position in CL in Q3 2024 and has held it in 9 quarters since. The position peaked at $552K in Q3 2024. 1,148 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Howard Capital Management held 4,961 shares of Colgate-Palmolive worth $423K as of Q3 2026.
  • Howard Capital Management sold 54 Colgate-Palmolive shares in Q3 2026, an estimated $4.89K.
  • Colgate-Palmolive made up 0.01% of Howard Capital Management's portfolio in Q3 2026, its #307 holding.
  • Howard Capital Management first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 9 quarters since.
  • Howard Capital Management's Colgate-Palmolive position peaked at $552K in Q3 2024.
  • 1,148 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Howard Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.